Company Ocean Biomedical, Inc.

Equities

OCEA

US67644C1045

Biotechnology & Medical Research

Real-time Estimate Cboe BZX 02:03:13 2024-05-20 pm EDT 5-day change 1st Jan Change
1.575 USD -10.51% Intraday chart for Ocean Biomedical, Inc. +3.29% +137.88%

Business Summary

Ocean Biomedical, Inc. is a biopharmaceutical company. The Company is focused on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The Company helps to accelerates the development and commercialization of assets from research universities and medical centers. In oncology, it is engaged in developing a mono-specific and two bi-specific humanized monoclonal antibodies (mAb), product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer (NSCLC), and of glioblastoma multiforme (GBM). It offers three product candidates based on the novel target discoveries: a malaria vaccine candidate targeting either or both of PfSEA-1, and parasite antigen PfGARP, which is referred to as its ODA-570 candidate; a humanized mAb malaria therapeutic candidate targeting PfGARP, which is referred to as ODA-611 candidate, and a small molecule malaria therapeutic candidate targeting PfGARP, which is referred to as ODA-579 candidate.

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 34,649,046 9,705,686 ( 28.01 %) 0 28.01 %

Shareholders

NameEquities%Valuation
22,799,608 65.80 % 29 M $
Polar Asset Management Partners, Inc.
7.758 %
2,688,193 7.758 % 3 M $
Aesther Healthcare Sponsor LLC
3.070 %
1,063,752 3.070 % 1 M $
1,063,750 3.070 % 1 M $
Rsn Associates LLC
1.443 %
500,000 1.443 % 627 500 $
BlackRock Advisors LLC
1.299 %
449,999 1.299 % 564 749 $
Vanguard Fiduciary Trust Co.
0.7811 %
270,652 0.7811 % 339 668 $
OMERS Administration Corp.
0.7082 %
245,400 0.7082 % 307 977 $
Geode Capital Management LLC
0.6738 %
233,448 0.6738 % 292 977 $
136,307 0.3934 % 171 065 $
NameEquities%Valuation
Privium Fund Management BV
-
518,537 - 58 076 $
EdgeHill Partners
-
399,078 - 44 697 $
EHP Funds, Inc.
-
316,510 - 35 449 $
Wolverine Asset Management LLC
-
316,325 - 35 428 $
Walleye Capital LLC
-
226,802 - 25 402 $
Boothbay Fund Management LLC
-
209,603 - 23 476 $
MMCAP International Inc. SPC
-
200,000 - 22 400 $
D.E. Shaw & Co., Inc.
-
182,154 - 20 401 $
Warberg Asset Management LLC
-
168,260 - 18 845 $
Walleye Trading LLC
-
127,576 - 14 289 $

Company contact information

Ocean Biomedical, Inc.

55 Claverick Street Room 325

02903, Providence

+

http://www.oceanbiomedical.com
address Ocean Biomedical, Inc.(OCEA)
  1. Stock Market
  2. Equities
  3. OCEA Stock
  4. Company Ocean Biomedical, Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW